News
Parmax Pharma reports standalone net loss of Rs 0.58 crore in the March 2026 quarter
04-Jun-2026 | 07:30
Sales decline 31.47% to Rs 3.31 crore
Net Loss of Parmax Pharma reported to Rs 0.58 crore in the quarter ended March 2026 as against net loss of Rs 1.49 crore during the previous quarter ended March 2025. Sales declined 31.47% to Rs 3.31 crore in the quarter ended March 2026 as against Rs 4.83 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 4.16 crore in the year ended March 2026 as against net loss of Rs 2.09 crore during the previous year ended March 2025. Sales declined 57.06% to Rs 12.11 crore in the year ended March 2026 as against Rs 28.20 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 3.31 | 4.83 | -31 | 12.11 | 28.20 | -57 |
| OPM % | -46.83 | -11.59 | - | -30.14 | 0.92 | - |
| PBDT | -2.02 | -0.90 | -124 | -4.84 | -0.29 | -1569 |
| PBT | -2.27 | -0.72 | -215 | -5.85 | -1.32 | -343 |
| NP | -0.58 | -1.49 | 61 | -4.16 | -2.09 | -99 |
Powered by Capital Market - Live News